HK Stock MarketDetailed Quotes

08622 HUAKANG BIOMED

Watchlist
  • 0.101
  • -0.005-4.72%
Not Open Apr 25 16:09 CST
50.55MMarket Cap-7769P/E (TTM)

HUAKANG BIOMED Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Turnover
-2.77%24.63M
-5.21%17.77M
-2.81%11.47M
-2.36%5.76M
-3.05%25.33M
0.98%18.75M
-3.08%11.8M
20.70%5.9M
18.94%26.13M
31.70%18.57M
Operating income
-2.77%24.63M
-5.21%17.77M
-2.81%11.47M
-2.36%5.76M
-3.05%25.33M
0.98%18.75M
-3.08%11.8M
20.70%5.9M
18.94%26.13M
31.70%18.57M
Cost of sales
-1.43%-8.54M
-1.03%-6.1M
5.34%-3.92M
8.50%-1.88M
12.98%-8.42M
10.53%-6.04M
10.09%-4.14M
-48.16%-2.06M
-33.41%-9.67M
-59.43%-6.75M
Operating expenses
-1.43%-8.54M
-1.03%-6.1M
5.34%-3.92M
8.50%-1.88M
12.98%-8.42M
10.53%-6.04M
10.09%-4.14M
-48.16%-2.06M
-33.41%-9.67M
-59.43%-6.75M
Gross profit
-4.85%16.09M
-8.17%11.67M
-1.45%7.54M
0.94%3.88M
2.78%16.91M
7.56%12.71M
1.19%7.66M
9.80%3.84M
11.81%16.46M
19.80%11.82M
Selling expenses
3.73%-8.62M
0.31%-6.14M
6.46%-3.76M
13.72%-1.87M
-7.25%-8.95M
-14.99%-6.16M
-6.85%-4.02M
-7.87%-2.17M
-17.15%-8.35M
-16.48%-5.36M
Administrative expenses
-0.72%-9.87M
0.23%-6M
-9.25%-4.21M
-1.62%-1.81M
-4.81%-9.8M
8.30%-6.01M
10.69%-3.85M
17.17%-1.79M
8.22%-9.35M
7.01%-6.55M
Research and development expenses
-2.82%-2.55M
-22.60%-2.43M
-19.15%-1.6M
-11.56%-743K
-1.89%-2.48M
-18.51%-1.98M
-5.67%-1.34M
-20.65%-666K
-8.17%-2.44M
-10.68%-1.67M
Impairment and provision
-372.65%-1.76M
-28.01%-521K
-29.17%-248K
----
41.44%-373K
36.90%-407K
22.89%-192K
96.67%-2K
80.91%-637K
13.31%-645K
-Other impairment is provision
-372.65%-1.76M
-28.01%-521K
-29.17%-248K
----
41.44%-373K
36.90%-407K
22.89%-192K
96.67%-2K
18.33%-637K
13.31%-645K
Operating interest expense
----
42.22%-26K
54.55%-15K
61.11%-7K
----
---45K
23.26%-33K
30.77%-18K
----
----
Special items of operating profit
-43.52%985K
-45.77%943K
-11.47%888K
-45.76%96K
237.98%1.74M
325.18%1.74M
582.31%1M
-5.85%177K
116.80%516K
117.98%409K
Operating profit
-94.07%-5.73M
-1,562.67%-2.49M
-78.90%-1.4M
25.77%-458K
22.34%-2.95M
92.49%-150K
59.40%-782K
44.56%-617K
66.46%-3.8M
68.33%-2M
Financing cost
3.64%-53K
----
----
----
46.08%-55K
----
----
----
---102K
-36.96%-63K
Earning before tax
-92.28%-5.78M
-1,562.67%-2.49M
-78.90%-1.4M
25.77%-458K
22.96%-3.01M
92.72%-150K
59.40%-782K
44.56%-617K
65.68%-3.9M
67.77%-2.06M
Tax
----
99.26%-3K
64.78%-56K
12.50%-56K
78.55%-68K
-43.11%-405K
-29.27%-159K
-77.78%-64K
-24.31%-317K
-0.35%-283K
After-tax profit from continuing operations
-88.03%-5.78M
-349.91%-2.5M
-54.62%-1.46M
24.52%-514K
27.13%-3.08M
76.32%-555K
54.08%-941K
40.73%-681K
63.71%-4.22M
64.89%-2.34M
Earning after tax
-88.03%-5.78M
-349.91%-2.5M
-54.62%-1.46M
24.52%-514K
27.13%-3.08M
76.32%-555K
54.08%-941K
40.73%-681K
63.71%-4.22M
64.89%-2.34M
Profit attributable to shareholders
-88.03%-5.78M
-349.91%-2.5M
-54.62%-1.46M
24.52%-514K
27.13%-3.08M
76.32%-555K
54.08%-941K
40.73%-681K
63.71%-4.22M
64.89%-2.34M
Basic earnings per share
-82.89%-0.0139
-361.54%-0.006
-45.83%-0.0035
29.41%-0.0012
28.30%-0.0076
77.59%-0.0013
52.94%-0.0024
41.38%-0.0017
63.57%-0.0106
65.27%-0.0058
Diluted earnings per share
-82.89%-0.0139
-361.54%-0.006
-45.83%-0.0035
29.41%-0.0012
28.30%-0.0076
77.59%-0.0013
52.94%-0.0024
41.38%-0.0017
63.57%-0.0106
65.27%-0.0058
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
China Audit Zhonghuan (Hong Kong) Certified Public Accountants Limited
--
--
--
China Audit Zhonghuan (Hong Kong) Certified Public Accountants Limited
--
--
--
China Audit Zhonghuan (Hong Kong) Certified Public Accountants Limited
--
(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Turnover -2.77%24.63M-5.21%17.77M-2.81%11.47M-2.36%5.76M-3.05%25.33M0.98%18.75M-3.08%11.8M20.70%5.9M18.94%26.13M31.70%18.57M
Operating income -2.77%24.63M-5.21%17.77M-2.81%11.47M-2.36%5.76M-3.05%25.33M0.98%18.75M-3.08%11.8M20.70%5.9M18.94%26.13M31.70%18.57M
Cost of sales -1.43%-8.54M-1.03%-6.1M5.34%-3.92M8.50%-1.88M12.98%-8.42M10.53%-6.04M10.09%-4.14M-48.16%-2.06M-33.41%-9.67M-59.43%-6.75M
Operating expenses -1.43%-8.54M-1.03%-6.1M5.34%-3.92M8.50%-1.88M12.98%-8.42M10.53%-6.04M10.09%-4.14M-48.16%-2.06M-33.41%-9.67M-59.43%-6.75M
Gross profit -4.85%16.09M-8.17%11.67M-1.45%7.54M0.94%3.88M2.78%16.91M7.56%12.71M1.19%7.66M9.80%3.84M11.81%16.46M19.80%11.82M
Selling expenses 3.73%-8.62M0.31%-6.14M6.46%-3.76M13.72%-1.87M-7.25%-8.95M-14.99%-6.16M-6.85%-4.02M-7.87%-2.17M-17.15%-8.35M-16.48%-5.36M
Administrative expenses -0.72%-9.87M0.23%-6M-9.25%-4.21M-1.62%-1.81M-4.81%-9.8M8.30%-6.01M10.69%-3.85M17.17%-1.79M8.22%-9.35M7.01%-6.55M
Research and development expenses -2.82%-2.55M-22.60%-2.43M-19.15%-1.6M-11.56%-743K-1.89%-2.48M-18.51%-1.98M-5.67%-1.34M-20.65%-666K-8.17%-2.44M-10.68%-1.67M
Impairment and provision -372.65%-1.76M-28.01%-521K-29.17%-248K----41.44%-373K36.90%-407K22.89%-192K96.67%-2K80.91%-637K13.31%-645K
-Other impairment is provision -372.65%-1.76M-28.01%-521K-29.17%-248K----41.44%-373K36.90%-407K22.89%-192K96.67%-2K18.33%-637K13.31%-645K
Operating interest expense ----42.22%-26K54.55%-15K61.11%-7K-------45K23.26%-33K30.77%-18K--------
Special items of operating profit -43.52%985K-45.77%943K-11.47%888K-45.76%96K237.98%1.74M325.18%1.74M582.31%1M-5.85%177K116.80%516K117.98%409K
Operating profit -94.07%-5.73M-1,562.67%-2.49M-78.90%-1.4M25.77%-458K22.34%-2.95M92.49%-150K59.40%-782K44.56%-617K66.46%-3.8M68.33%-2M
Financing cost 3.64%-53K------------46.08%-55K---------------102K-36.96%-63K
Earning before tax -92.28%-5.78M-1,562.67%-2.49M-78.90%-1.4M25.77%-458K22.96%-3.01M92.72%-150K59.40%-782K44.56%-617K65.68%-3.9M67.77%-2.06M
Tax ----99.26%-3K64.78%-56K12.50%-56K78.55%-68K-43.11%-405K-29.27%-159K-77.78%-64K-24.31%-317K-0.35%-283K
After-tax profit from continuing operations -88.03%-5.78M-349.91%-2.5M-54.62%-1.46M24.52%-514K27.13%-3.08M76.32%-555K54.08%-941K40.73%-681K63.71%-4.22M64.89%-2.34M
Earning after tax -88.03%-5.78M-349.91%-2.5M-54.62%-1.46M24.52%-514K27.13%-3.08M76.32%-555K54.08%-941K40.73%-681K63.71%-4.22M64.89%-2.34M
Profit attributable to shareholders -88.03%-5.78M-349.91%-2.5M-54.62%-1.46M24.52%-514K27.13%-3.08M76.32%-555K54.08%-941K40.73%-681K63.71%-4.22M64.89%-2.34M
Basic earnings per share -82.89%-0.0139-361.54%-0.006-45.83%-0.003529.41%-0.001228.30%-0.007677.59%-0.001352.94%-0.002441.38%-0.001763.57%-0.010665.27%-0.0058
Diluted earnings per share -82.89%-0.0139-361.54%-0.006-45.83%-0.003529.41%-0.001228.30%-0.007677.59%-0.001352.94%-0.002441.38%-0.001763.57%-0.010665.27%-0.0058
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion------Unqualified Opinion------Unqualified Opinion--
Auditor China Audit Zhonghuan (Hong Kong) Certified Public Accountants Limited------China Audit Zhonghuan (Hong Kong) Certified Public Accountants Limited------China Audit Zhonghuan (Hong Kong) Certified Public Accountants Limited--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg